Company / Current Assets
Bristol Myers Squibb Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$29.4B
FY2025
5-year range
$27.3B / $33.3B
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#5 of 213
Health Care
What the data says
Among 213 Health Care companies, Bristol Myers Squibb is in the top 2% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $13.7B in FY2016 to $33.3B in FY2021.
Based on SEC 10-K filings.
$29.4B in FY2025 with a 5-year CAGR of -0.5%. Top quartile in the Health Care sector.
Declined from $31.8B to $29.4B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- -0.5%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 213This company $29.4B Sector average $2.5B
▼
+1065.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.5%, indicating a declining trend.
- In FY2025, current assets decreased 1.3% year-over-year.
- Ranks #5 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.4B | -1.3% |
| FY2024 | $29.8B | -6.3% |
| FY2023 | $31.8B | +16.5% |
| FY2022 | $27.3B | -18.0% |
| FY2021 | $33.3B | +10.2% |
| FY2020 | $30.2B | +2.9% |
| FY2019 | $29.4B | +71.1% |
| FY2018 | $17.2B | +15.5% |
| FY2017 | $14.9B | +8.4% |
| FY2016 | $13.7B | +31.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026